Fig. 2From: Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancerBiodistribution of [111In]In-DOTA-cetuximab at 48 h in mice xenograft models with non-small cell lung cancer (NSCLC) tumors with varying epidermal growth factor receptor (EGFR) expression levels. Each data point represents the mean ± SD of n = 5 to 7 per tumor modelBack to article page